Bioconjugate & ADC Technology Transfer

Abzena delivers a comprehensive approach to bioconjugate and ADC technology transfer, supporting seamless transition of bioconjugate manufacturing processes from development to commercial production.

Fast-track your tech transfer with Abzena.

Through a comprehensive bioconjugation technology transfer process, Abzena delivers a reliable scale-up model that ensures a robust and consistent manufacturing process from clinical development through commercial production.

We work closely with your team to de-risk the pathway to commercialization, confirm manufacturability, and deliver high-quality bioconjugates to patients through our integrated bioconjugation services and CDMO technology transfer expertise.

Our risk-based approach captures process knowledge and analytical data across each phase of bioconjugate development. This ensures seamless transfer of bioconjugate technologies and ADC technology into full-scale GMP manufacturing while incorporating regulatory feedback for long-term program success.

Contact Us

Bioconjugate Tech Transfer Approach

Adaptable to each project, our team of scientific leaders applies deep expertise in bioconjugates, chemistry, and problem solving. We can deliver complex projects within narrow timelines by maintaining effective communication and transparency of data throughout each technology transfer phase.

Committed to quality, we ensure continued supply of your products according to your predefined specifications. All processes within our bioconjugation services and technology transfer operations follow cGMP manufacturing regulations, supporting reliable scale-up and long-term performance of advanced bioconjugate technologies.

Contact Us

Dedicated Technology Transfer Project Team

Bioconjugates, ADCs & Chemistry CRO+CDMO - Abzena

Your project will have a dedicated team appropriate to its requirements. They work relentlessly to ensure the efficient and responsible delivery of your transfer. Each team consists of a lead for:

Having a tech transfer plan is easier than you think

It is never too early to start researching which CDMO is the best partner for your biologics program. Technology transfers may not be easy, starting a conversation with Abzena’s scientific team is. We are ready to help move your medicine forward.

Contact Us

Bioconjugate & ADC Technology Transfer FAQs

How does Abzena manage technology transfer for bioconjugate development?

Abzena uses a structured, risk-based bioconjugation transfer process that captures data, analytics, and process knowledge to ensure reliable bioconjugate development from lab to GMP scale.

What role does bioconjugate chemistry play in ADC technology?

Bioconjugate chemistry determines how antibodies are linked to cytotoxic or functional payloads. It is key to achieving stable, reproducible ADC technologies with consistent performance.

How does Abzena ensure quality during technology transfer?

All bioconjugation services follow cGMP standards and validated analytical controls, ensuring each transferred process meets predefined specifications for quality and compliance.

What bioconjugate technologies does Abzena support?

Abzena supports a full range of bioconjugate technologies. This includes ADC technology, and novel conjugation methods for antibody-oligonucleotides (AOCs), peptides and other therapeutic modalities.

Related Services

Process Performance & Qualification (PPQ)

Ensuring your process reliably delivers high-quality, safe products as you scale-up, our experienced scientists and engineers use their extensive knowledge to develop tailored PPQ strategies.

Learn More

Quality Control & Stability

Accelerating your path, we develop, execute and document phase appropriate methods necessary to produce high-quality, well-characterized material and the data to support successful BLA and ...

Learn More

Bioconjugate Clinical Through Commercial cGMP Manufacturing

We are experienced in offering reliable, predictable clinical to commercial cGMP bioconjugates & ADC manufacturing.

Learn More

Latest News & Insights

Blog

A Look into Leading Operations: Colleague Spotlight on Edward Rivera

Read More

Articles

BioPharm International: Reducing Timelines and Eliminating the White Space in Complex Biologic & Bioconjugate Development

Read More

Blog

Part 2 of 3: The Importance of Developability Assessments – From Design to Selection – How Developability Guides Effective Lead Optimization

Read More

Let's get started.

Our team collaborates with you and uses deep scientific and technical know-how to find the best solutions using the right technologies to transfer your program with a constant commitment to quality.

Contact Us